78 Biggest Movers From Friday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
Mid-Afternoon Market Update: Honest Co Falls After Q2 Results; Pilgrim’s Pride Shares Jump
Toward the end of trading Friday, the Dow traded up 0.03% to 35,510.30 while the NASDAQ fell 0.02% to 14,813.66. The S&P also rose, gaining 0.09% to 4,464.72.
Mid-Day Market Update: Gold Rises Over 1%; Duos Technologies Shares Plummet
Midway through trading Friday, the Dow traded up 0.07% to 35,525.67 while the NASDAQ rose 0.03% to 14,821.05. The S&P also rose, gaining 0.07% to 4,463.78.
Mid-Morning Market Update: Markets Edge Higher; Disney Reports Upbeat Q3 Earnings
Following the market opening Friday, the Dow traded up 0.04% to 35,512.89 while the NASDAQ rose 0.20% to 14,845.17. The S&P also rose, gaining 0.11% to 4,465.85.
SOC Telemed Stock Tumbles After Lowering FY21 Revenue Guidance
SOC Telemed Inc (NASDAQ:TLMD) reported Q2 revenue of $24.96 million, +84% Y/Y, but slightly lower than the consensus of $25.18…
RBC Capital Maintains Outperform on SOC Telemed, Lowers Price Target to $6
RBC Capital analyst Sean Dodge maintains SOC Telemed (NASDAQ:TLMD) with a Outperform and lowers the price target from $10 to $6.
Credit Suisse Maintains Outperform on SOC Telemed, Lowers Price Target to $8.5
Credit Suisse analyst Jailendra Singh maintains SOC Telemed (NASDAQ:TLMD) with a Outperform and lowers the price target from $11 to $8.5.